Investor Stock List
Ranked #5,008 of 8,699 institutional investors

Squadron Capital Management LLC

Oak Brook, IL

$299M
US stock portfolio at live prices · today +$1.3M (+0.45%)
Market closed. Prices as of Nov 20, 8:41 AM ET
Value at quarter end (Q3 2026)
$337M
Change from Q2 2026
+$45.3M (+15.52%)
Positions
29 · 11 new, 10 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $61.0M of stock. $30.9M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
SLN 13.8%KOD 13.8%COGT 8.49%CCCC 7.61%EWTX 5.86%
StockSharesValue, live% of portfoliovs Q2 2026
SLN Silence Therapeutics plc2,085,000$41.3M13.8%New
KOD Kodiak Sciences Inc.420,000$41.1M13.8%Reduced −16%
COGT Cogent Biosciences, Inc.915,000$25.4M8.49%Added +6%
CCCC C4 Therapeutics, Inc.9,318,683$22.7M7.61%Added +29%
EWTX Edgewise Therapeutics, Inc.425,000$17.5M5.86%Added +47%
RLAY Relay Therapeutics, Inc.785,000$12.5M4.18%Reduced −19%
RLMD Relmada Therapeutics, Inc.3,500,000$10.9M3.64%Reduced −52%
DFTX Definium Therapeutics, Inc.340,000$10.0M3.35%Added +300%
ZNTL Zentalis Pharmaceuticals, Inc.6,827,905$9.3M3.11%Added +85%
IVA Inventiva S.A.2,400,000$8.3M2.77%Reduced −1%
VERA Vera Therapeutics, Inc.305,000$8.2M2.73%New
ORIC ORIC Pharmaceuticals, Inc.1,000,000$7.7M2.58%New
ANL Adlai Nortye Group Ltd.764,876$6.9M2.32%Unchanged
ASMB Assembly Biosciences, Inc.225,000$5.1M1.69%Added +41%
ACRS Aclaris Therapeutics, Inc.1,200,000$4.2M1.41%New
IRLA IRulya Therapeutics Inc.90,000$3.6M1.20%Added +123%
SVRA Savara Inc.675,000$3.5M1.18%New
TNGX Tango Therapeutics, Inc.150,000$3.4M1.14%New
ADAG Adagene Inc.1,616,618$3.2M1.09%Added +29%
YARW Yarrow Bioscience, Inc.225,000$3.2M1.07%New
AVTX Avalo Therapeutics, Inc.450,000$3.0M1.02%New
CTNM Contineum Therapeutics, Inc.323,570$2.9M0.98%Added +24%
PALI Palisade Bio, Inc.3,000,000$2.8M0.93%Unchanged
IKT Inhibikase Therapeutics, Inc.2,000,000$2.6M0.87%Reduced −33%
PEPG PepGen Inc.600,000$2.4M0.79%New
JANX Janux Therapeutics, Inc.215,000$2.2M0.74%New
ALXO ALX Oncology Holdings Inc.1,400,000$1.4M0.48%New
SCYX SCYNEXIS, Inc.515,045$1.3M0.45%Reduced −32%
LPCN Lipocine Inc.810,000$1.2M0.41%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
MAZE Maze Therapeutics, Inc.335,000$10.9M
ELVN Enliven Therapeutics, Inc.160,000$7.4M
CMPS COMPASS Pathways plc300,000$2.6M
RZLT Rezolute, Inc.403,410$1.7M
PMN ProMIS Neurosciences, Inc.324,977$1.0M
BIOA BioAge Labs, Inc.155,000$730K
KTTA Pasithea Therapeutics Corp.1,000,000$481K
NXTC NextCure, Inc.64,464$437K
CUE Cue Biopharma, Inc.50,000$225K
NMRA Neumora Therapeutics, Inc.100,000$35K